We are live on ! Find out more
CA

Cortland Associates Portfolio holdings

AUM $692M
1-Year Est. Return 5%
This Fund
S&P 500
This Quarter Est. Return
+9.68%
1 Year Est. Return
-5%
3 Year Est. Return
+57.07%
5 Year Est. Return
+61.48%
10 Year Est. Return
+413.35%
AUM
$516M
AUM Growth
+$84.7M
Cap. Flow
+$46.8M
Cap. Flow %
9.07%
Top 10 Hldgs %
72.32%
Holding
48
New
4
Increased
15
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$15.2M
2
PRGO icon
Perrigo
PRGO
+$15.2M
3
ESRX
Express Scripts Holding Company
ESRX
+$6.61M
4
CVS icon
CVS Health
CVS
+$6.08M
5
CTSH icon
Cognizant
CTSH
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 35.55%
2 Financials 24.39%
3 Technology 12.85%
4 Communication Services 11.51%
5 Consumer Discretionary 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
26
Apple
AAPL
$4.52T
$406K 0.08%
15,412
-1,232
-7% -$35.2K
IWB icon
27
iShares Russell 1000 ETF
IWB
$49.9B
$371K 0.07%
3,275
IYY icon
28
iShares Dow Jones US ETF
IYY
$3.05B
$370K 0.07%
7,250
BRK.B icon
29
Berkshire Hathaway Class B
BRK.B
$1.12T
$351K 0.07%
2,655
SHW icon
30
Sherwin-Williams
SHW
$87.8B
$337K 0.07%
3,900
MO icon
31
Altria Group
MO
$114B
$332K 0.06%
5,699
+16
+0.3% +$927
MSFT icon
32
Microsoft
MSFT
$3.66T
$267K 0.05%
4,810
XOM icon
33
ExxonMobil
XOM
$638B
$265K 0.05%
3,399
-357
-10% -$28.5K
PBA icon
34
Pembina Pipeline
PBA
$28.1B
$260K 0.05%
11,939
PG icon
35
Procter & Gamble
PG
$345B
$233K 0.05%
2,929
-276
-9% -$21.1K
PCG icon
36
PG&E
PCG
$38.4B
$231K 0.04%
4,339
CELG
37
DELISTED
Celgene Corp
CELG
$224K 0.04%
1,870
-30
-2% -$3.47K
EFG icon
38
iShares MSCI EAFE Growth ETF
EFG
$17B
$211K 0.04%
3,150
QMCO icon
39
Quantum Corp
QMCO
$451M
$19K ﹤0.01%
+127
New +$17.4K
AHPI
40
DELISTED
Allied Healthcare Products
AHPI
$11K ﹤0.01%
5,000
VIVS
41
VivoSim Labs
VIVS
$1.28M
-46
Closed -$29K
ECYT
42
DELISTED
Endocyte, Inc. Common Stock
ECYT
-40,000
Closed -$183K
TSCC
43
DELISTED
TECHNOLOGY SOLUTIONS CO NEW
TSCC
-12,625
Closed
HK
44
DELISTED
Halcon Resources Corporation
HK
-203
Closed -$19K

Similar funds

Cortland Associates's Q4 2015 Portfolio in Review

As of Q4 2015, Cortland Associates held 48 positions worth $516M, up 20% from $431M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Cortland Associates deployed $46.8M of net new capital in Q4 2015, opening 4 new positions and adding to 15 existing holdings. Its largest new stake was Centene: 512,304 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 31% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Monsanto Co, an estimated $442K trimmed.

  • Cortland Associates's largest Q4 2015 buy was Centene: 512,304 shares worth $16.9M.
  • Cortland Associates added most to Express Scripts Holding Company in Q4 2015, an estimated $6.61M increase.
  • Cortland Associates's biggest Q4 2015 reduction was Monsanto Co, cutting an estimated $442K.
  • Cortland Associates fully exited Endocyte, Inc. Common Stock in Q4 2015, selling an estimated $183K.
  • Cortland Associates's ten largest holdings make up 72% of its $516M portfolio in Q4 2015.
  • Cortland Associates opened 4 new positions and closed 4 in Q4 2015.
  • Cortland Associates's portfolio value rose 20% quarter-over-quarter to $516M.

Based on Cortland Associates's 13F filing for Q4 2015, filed 19 Jan 2016.